HLA B*51 Disease Association
Also known as: B*51:01, B51, Behcet, Behcet Disease, Behcet's Disease
Use
Behcet Disease (BD) is a rare, chronic, multisystem disease caused by vasculitis of blood vessels throughout the body. The disease course is marked by recurrent ulcers of the oral and genital regions, often with severe ocular inflammation that may lead to visual impairment or blindness. This disease is found most often in individuals that carry the HLA B*51 allele of the major histocompatibily complex (MHC). HLA B*51 is the predominant risk factor for BD in all populations studied, however not all BD patients carry the B*51 allele. The disease is prevalent in countries in the eastern Mediterranean, the Middle East, and East Asia and in individuals of Middle Eastern, Far Eastern and Mediterranean decent.
Special Instructions
For inquiries and test selection assistance, contact HLA customer service at 800-533-1037. It is crucial to select the appropriate HLA test for accurate diagnostics of Behcet Disease.
Limitations
This test has been developed and its performance characteristics determined by LabCorp. However, it has not been cleared or approved by the US Food and Drug Administration. A negative result for HLA-B*51 does not rule out the diagnosis of Behcet's Disease in the tested individual. Additional confirmatory testing may be necessary for conclusive results.
Methodology
NGS
Biomarkers
LOINC Codes
- 13299-3
- 13299-3
- 49549-9
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL
Minimum Volume
3 mL
Container
Lavender-top (EDTA) tube
Storage Instructions
Maintain specimen at room temperature; protect from extreme heat or cold. Do not freeze.
Causes for Rejection
Hemolyzed specimen; clotted specimen; wrong specimen container
